COVID-19 illness was virtually prevented in hamsters administered BiondVax’s inhaled NanoAb and infected three hours later with SARS-CoV-2 Data further.
BiondVax’s Innovative Inhaled Anti-SARS-CoV-2 NanoAb Virtually Prevented Illness When Administered Prophylactically in Preclinical In Vivo Study - read this article along with other careers information, tips and advice on BioSpace
In a preclinical in vivo study, the viral presence in the lungs of hamsters treated with BiondVax’s inhaled nanosized antibody COVID-19 therapy was essentially eliminated.
BiondVax’s Innovative Inhaled COVID-19 Therapy Virtually Eliminated SARS-COV-2 Virus in Preclinical In Vivo Study - read this article along with other careers information, tips and advice on BioSpace